Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2000 Apr;76(2):80–87. doi: 10.1136/sti.76.2.80

Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?

I Simms 1, J Stephenson 1
PMCID: PMC1758284  PMID: 10858707

Full Text

The Full Text of this article is available as a PDF (142.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler M. W. Trends for gonorrhea and pelvic inflammatory disease in England and Wales and for gonorrhea in a defined population. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):901–904. doi: 10.1016/0002-9378(80)91079-0. [DOI] [PubMed] [Google Scholar]
  2. Bevan C. D., Johal B. J., Mumtaz G., Ridgway G. L., Siddle N. C. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. Br J Obstet Gynaecol. 1995 May;102(5):407–414. doi: 10.1111/j.1471-0528.1995.tb11294.x. [DOI] [PubMed] [Google Scholar]
  3. Blackwell A. L., Thomas P. D., Wareham K., Emery S. J. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet. 1993 Jul 24;342(8865):206–210. doi: 10.1016/0140-6736(93)92299-9. [DOI] [PubMed] [Google Scholar]
  4. Brihmer C., Kallings I., Nord C. E., Brundin J. Salpingitis; aspects of diagnosis and etiology: a 4-year study from a Swedish capital hospital. Eur J Obstet Gynecol Reprod Biol. 1987 Mar;24(3):211–220. doi: 10.1016/0028-2243(87)90020-7. [DOI] [PubMed] [Google Scholar]
  5. Brunham R. C., Binns B., Guijon F., Danforth D., Kosseim M. L., Rand F., McDowell J., Rayner E. Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis. 1988 Sep;158(3):510–517. doi: 10.1093/infdis/158.3.510. [DOI] [PubMed] [Google Scholar]
  6. Brunham R. C., Peeling R., Maclean I., Kosseim M. L., Paraskevas M. Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates. J Infect Dis. 1992 Jun;165(6):1076–1081. doi: 10.1093/infdis/165.6.1076. [DOI] [PubMed] [Google Scholar]
  7. Buchan H., Vessey M. Epidemiology and trends in hospital discharges for pelvic inflammatory disease in England, 1975 to 1985. Br J Obstet Gynaecol. 1989 Oct;96(10):1219–1223. doi: 10.1111/j.1471-0528.1989.tb03200.x. [DOI] [PubMed] [Google Scholar]
  8. Buchan H., Vessey M., Goldacre M., Fairweather J. Morbidity following pelvic inflammatory disease. Br J Obstet Gynaecol. 1993 Jun;100(6):558–562. doi: 10.1111/j.1471-0528.1993.tb15308.x. [DOI] [PubMed] [Google Scholar]
  9. Cacciatore B., Leminen A., Ingman-Friberg S., Ylöstalo P., Paavonen J. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease. Obstet Gynecol. 1992 Dec;80(6):912–916. [PubMed] [Google Scholar]
  10. Cates W., Jr, Rolfs R. T., Jr, Aral S. O. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev. 1990;12:199–220. doi: 10.1093/oxfordjournals.epirev.a036054. [DOI] [PubMed] [Google Scholar]
  11. Cohen C. R., Brunham R. C. Pathogenesis of Chlamydia induced pelvic inflammatory disease. Sex Transm Infect. 1999 Feb;75(1):21–24. doi: 10.1136/sti.75.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Coutinho R. A., Rijsdijk A. J., van den Hoek J. A., Leentvaar-Kuijpers A. Decreasing incidence of PID in Amsterdam. Genitourin Med. 1992 Dec;68(6):353–355. doi: 10.1136/sti.68.6.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Egger M., Low N., Smith G. D., Lindblom B., Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ. 1998 Jun 13;316(7147):1776–1780. doi: 10.1136/bmj.316.7147.1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Eschenbach D. A., Harnisch J. P., Holmes K. K. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol. 1977 Aug 15;128(8):838–850. doi: 10.1016/0002-9378(77)90051-5. [DOI] [PubMed] [Google Scholar]
  15. Eschenbach D. A., Hillier S., Critchlow C., Stevens C., DeRouen T., Holmes K. K. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol. 1988 Apr;158(4):819–828. doi: 10.1016/0002-9378(88)90078-6. [DOI] [PubMed] [Google Scholar]
  16. Evans B. G., Catchpole M. A., Heptonstall J., Mortimer J. Y., McCarrigle C. A., Nicoll A. G., Waight P., Gill O. N., Swan A. V. Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales. BMJ. 1993 Feb 13;306(6875):426–428. doi: 10.1136/bmj.306.6875.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Forrest K. A., Washington A. E., Daling J. R., Sweet R. L. Vaginal douching as a possible risk factor for pelvic inflammatory disease. J Natl Med Assoc. 1989 Feb;81(2):159–165. [PMC free article] [PubMed] [Google Scholar]
  18. Genç M., Mårdh A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):1–7. doi: 10.7326/0003-4819-124-1_part_1-199601010-00001. [DOI] [PubMed] [Google Scholar]
  19. Hadgu A., Westrom L., Brooks C. A., Reynolds G. H., Thompson S. E. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol. 1986 Nov;155(5):954–960. doi: 10.1016/0002-9378(86)90324-8. [DOI] [PubMed] [Google Scholar]
  20. Hager W. D., Eschenbach D. A., Spence M. R., Sweet R. L. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol. 1983 Jan;61(1):113–114. [PubMed] [Google Scholar]
  21. Hansson H., Danielsson D. Epidemiology of sexually transmitted diseases in the Scandinavian countries. Scand J Infect Dis Suppl. 1982;32:149–156. [PubMed] [Google Scholar]
  22. Heinonen P. K., Teisala K., Miettinen A., Aine R., Punnonen R., Grönroos P. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. Scand J Infect Dis Suppl. 1989;60:66–73. [PubMed] [Google Scholar]
  23. Hersey P., Prendergast D., Edwards A. Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust. 1983 Oct 29;2(9):425–429. [PubMed] [Google Scholar]
  24. Hillis S. D., Joesoef R., Marchbanks P. A., Wasserheit J. N., Cates W., Jr, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol. 1993 May;168(5):1503–1509. doi: 10.1016/s0002-9378(11)90790-x. [DOI] [PubMed] [Google Scholar]
  25. Hillis S. D., Nakashima A., Amsterdam L., Pfister J., Vaughn M., Addiss D., Marchbanks P. A., Owens L. M., Davis J. P. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspect. 1995 May-Jun;27(3):108–111. [PubMed] [Google Scholar]
  26. Hiltunen-Back E., Rostila T., Kautiainen H., Paavonen J., Reunala T. Rapid decrease of endemic gonorrhea in Finland. Sex Transm Dis. 1998 Apr;25(4):181–186. doi: 10.1097/00007435-199804000-00001. [DOI] [PubMed] [Google Scholar]
  27. Hughes G., Simms I., Rogers P. A., Swan A. V., Catchpole M. New cases seen at genitourinary medicine clinics: England 1997. Commun Dis Rep CDR Suppl. 1998 Dec;8(7):S1–11. [PubMed] [Google Scholar]
  28. Jacobson L., Weström L. Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol. 1969 Dec 1;105(7):1088–1098. doi: 10.1016/0002-9378(69)90132-x. [DOI] [PubMed] [Google Scholar]
  29. Jossens M. O., Schachter J., Sweet R. L. Risk factors associated with pelvic inflammatory disease of differing microbial etiologies. Obstet Gynecol. 1994 Jun;83(6):989–997. doi: 10.1097/00006250-199406000-00019. [DOI] [PubMed] [Google Scholar]
  30. Kamwendo F., Forslin L., Bodin L., Danielsson D. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden. Sex Transm Dis. 1996 Sep-Oct;23(5):384–391. doi: 10.1097/00007435-199609000-00007. [DOI] [PubMed] [Google Scholar]
  31. Kamwendo F., Forslin L., Bodin L., Danielsson D. Programmes to reduce pelvic inflammatory disease--the Swedish experience. Lancet. 1998;351 (Suppl 3):25–28. doi: 10.1016/s0140-6736(98)90008-3. [DOI] [PubMed] [Google Scholar]
  32. Kinghorn G. R., Duerden B. I., Hafiz S. Clinical and microbiological investigation of women with acute salpingitis and their consorts. Br J Obstet Gynaecol. 1986 Aug;93(8):869–880. doi: 10.1111/j.1471-0528.1986.tb07997.x. [DOI] [PubMed] [Google Scholar]
  33. Kiviat N. B., Wølner-Hanssen P., Peterson M., Wasserheit J., Stamm W. E., Eschenbach D. A., Paavonen J., Lingenfelter J., Bell T., Zabriskie V. Localization of Chlamydia trachomatis infection by direct immunofluorescence and culture in pelvic inflammatory disease. Am J Obstet Gynecol. 1986 Apr;154(4):865–873. doi: 10.1016/0002-9378(86)90473-4. [DOI] [PubMed] [Google Scholar]
  34. Korn A. P., Hessol N., Padian N., Bolan G., Muzsnai D., Donegan E., Jonte J., Schachter J., Landers D. V. Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis. Sex Transm Dis. 1995 Nov-Dec;22(6):335–341. doi: 10.1097/00007435-199511000-00002. [DOI] [PubMed] [Google Scholar]
  35. Livengood C. H., 3rd, Hill G. B., Addison W. A. Pelvic inflammatory disease: findings during inpatient treatment of clinically severe, laparoscopy-documented disease. Am J Obstet Gynecol. 1992 Feb;166(2):519–524. doi: 10.1016/0002-9378(92)91661-s. [DOI] [PubMed] [Google Scholar]
  36. Marchbanks P. A., Lee N. C., Peterson H. B. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol. 1990 Mar;162(3):639–644. doi: 10.1016/0002-9378(90)90973-b. [DOI] [PubMed] [Google Scholar]
  37. Meirik O. Ectopic pregnancy during 1961-78 in Uppsala county, Sweden. Impact of demographic factors on overall incidence. Acta Obstet Gynecol Scand. 1981;60(6):545–548. doi: 10.3109/00016348109155483. [DOI] [PubMed] [Google Scholar]
  38. Paavonen J. Chlamydia trachomatis in acute salpingitis. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):957–959. doi: 10.1016/0002-9378(80)91086-8. [DOI] [PubMed] [Google Scholar]
  39. Paavonen J., Puolakkainen M., Paukku M., Sintonen H. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol. 1998 Aug;92(2):292–298. doi: 10.1016/s0029-7844(98)00167-7. [DOI] [PubMed] [Google Scholar]
  40. Paavonen J., Teisala K., Heinonen P. K., Aine R., Laine S., Lehtinen M., Miettinen A., Punnonen R., Grönroos P. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol. 1987 May;94(5):454–460. doi: 10.1111/j.1471-0528.1987.tb03125.x. [DOI] [PubMed] [Google Scholar]
  41. Pasley J. N., Rank R. G., Hough A. J., Jr, Cohen C., Barron A. L. Effects of various doses of estradiol on chlamydial genital infection in ovariectomized guinea pigs. Sex Transm Dis. 1985 Jan-Mar;12(1):8–13. doi: 10.1097/00007435-198501000-00003. [DOI] [PubMed] [Google Scholar]
  42. Pearce J. M. Pelvic inflammatory disease. BMJ. 1990 Apr 28;300(6732):1090–1091. doi: 10.1136/bmj.300.6732.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ripa K. T., Svensson L., Treharne J. D., Weström L., Mårdh P. A. Chlamydia trachomatis infection in patients with laparoscopically verified acute salpingitis. Results of isolation and antibody determinations. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):960–964. doi: 10.1016/0002-9378(80)91087-x. [DOI] [PubMed] [Google Scholar]
  44. Risch H. A., Howe G. R. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):447–451. [PubMed] [Google Scholar]
  45. Robinson A. J., Greenhouse P. Prevention of recurrent pelvic infection by contact tracing: a commonsense approach. Br J Obstet Gynaecol. 1996 Sep;103(9):859–861. doi: 10.1111/j.1471-0528.1996.tb09901.x. [DOI] [PubMed] [Google Scholar]
  46. Robinson N., Beral V., Ashley J. S. Trends in pelvic inflammatory disease in England and Wales. J Epidemiol Community Health. 1981 Dec;35(4):265–270. doi: 10.1136/jech.35.4.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Rolfs R. T. "Think PID". New directions in prevention and management of pelvic inflammatory disease. Sex Transm Dis. 1991 Apr-Jun;18(2):131–132. [PubMed] [Google Scholar]
  48. Scholes D., Daling J. R., Stergachis A. S. Current cigarette smoking and risk of acute pelvic inflammatory disease. Am J Public Health. 1992 Oct;82(10):1352–1355. doi: 10.2105/ajph.82.10.1352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Scholes D., Daling J. R., Stergachis A., Weiss N. S., Wang S. P., Grayston J. T. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol. 1993 Apr;81(4):601–606. [PubMed] [Google Scholar]
  50. Scholes D., Stergachis A., Heidrich F. E., Andrilla H., Holmes K. K., Stamm W. E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996 May 23;334(21):1362–1366. doi: 10.1056/NEJM199605233342103. [DOI] [PubMed] [Google Scholar]
  51. Sellors J., Mahony J., Goldsmith C., Rath D., Mander R., Hunter B., Taylor C., Groves D., Richardson H., Chernesky M. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):113–120. doi: 10.1016/0002-9378(91)90639-9. [DOI] [PubMed] [Google Scholar]
  52. Simms I., Catchpole M., Brugha R., Rogers P., Mallinson H., Nicoll A. Epidemiology of genital Chlamydia trachomatis in England and Wales. Genitourin Med. 1997 Apr;73(2):122–126. doi: 10.1136/sti.73.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Simms I., Hughes G., Catchpole M. Screening for Chlamydia trachomatis. New methods are needed to assess the burden of illness from chlamydia. BMJ. 1998 Sep 5;317(7159):680–681. doi: 10.1136/bmj.317.7159.680a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Simms I., Rogers P. A., Nicoll A. The influence of demographic change and cumulative risk of pelvic inflammatory disease on the incidence of ectopic pregnancy. Epidemiol Infect. 1997 Aug;119(1):49–52. doi: 10.1017/s0950268897007711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Simms I., Rogers P., Charlett A. The rate of diagnosis and demography of pelvic inflammatory disease in general practice: England and Wales. Int J STD AIDS. 1999 Jul;10(7):448–451. doi: 10.1258/0956462991914447. [DOI] [PubMed] [Google Scholar]
  56. Sinei S. K., Schulz K. F., Lamptey P. R., Grimes D. A., Mati J. K., Rosenthal S. M., Rosenberg M. J., Riara G., Njage P. N., Bhullar V. B. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynaecol. 1990 May;97(5):412–419. doi: 10.1111/j.1471-0528.1990.tb01828.x. [DOI] [PubMed] [Google Scholar]
  57. Soper D. E., Brockwell N. J., Dalton H. P., Johnson D. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol. 1994 Apr;170(4):1008–1017. doi: 10.1016/s0002-9378(94)70094-x. [DOI] [PubMed] [Google Scholar]
  58. Stacey C. M., Munday P. E., Taylor-Robinson D., Thomas B. J., Gilchrist C., Ruck F., Ison C. A., Beard R. W. A longitudinal study of pelvic inflammatory disease. Br J Obstet Gynaecol. 1992 Dec;99(12):994–999. doi: 10.1111/j.1471-0528.1992.tb13705.x. [DOI] [PubMed] [Google Scholar]
  59. Stamm W. E., Guinan M. E., Johnson C., Starcher T., Holmes K. K., McCormack W. M. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med. 1984 Mar 1;310(9):545–549. doi: 10.1056/NEJM198403013100901. [DOI] [PubMed] [Google Scholar]
  60. Sweet R. L. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis. 1995 Jun;20 (Suppl 2):S271–S275. doi: 10.1093/clinids/20.supplement_2.s271. [DOI] [PubMed] [Google Scholar]
  61. Swenson C. E., Schachter J. Infertility as a consequence of chlamydial infection of the upper genital tract in female mice. Sex Transm Dis. 1984 Apr-Jun;11(2):64–67. doi: 10.1097/00007435-198404000-00002. [DOI] [PubMed] [Google Scholar]
  62. Toye B., Laferrière C., Claman P., Jessamine P., Peeling R. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis. 1993 Nov;168(5):1236–1240. doi: 10.1093/infdis/168.5.1236. [DOI] [PubMed] [Google Scholar]
  63. Tukeva T. A., Aronen H. J., Karjalainen P. T., Molander P., Paavonen T., Paavonen J. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology. 1999 Jan;210(1):209–216. doi: 10.1148/radiology.210.1.r99ja04209. [DOI] [PubMed] [Google Scholar]
  64. Vessey M., Doll R., Peto R., Johnson B., Wiggins P. A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci. 1976 Oct;8(4):373–427. doi: 10.1017/s0021932000010890. [DOI] [PubMed] [Google Scholar]
  65. Washington A. E., Aral S. O., Wølner-Hanssen P., Grimes D. A., Holmes K. K. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA. 1991 Nov 13;266(18):2581–2586. [PubMed] [Google Scholar]
  66. Washington A. E., Katz P. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA. 1991 Nov 13;266(18):2565–2569. [PubMed] [Google Scholar]
  67. Wasserheit J. N., Bell T. A., Kiviat N. B., Wølner-Hanssen P., Zabriskie V., Kirby B. D., Prince E. C., Holmes K. K., Stamm W. E., Eschenbach D. A. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med. 1986 Feb;104(2):187–193. doi: 10.7326/0003-4819-104-2-187. [DOI] [PubMed] [Google Scholar]
  68. Weström L. V. Sexually transmitted diseases and infertility. Sex Transm Dis. 1994 Mar-Apr;21(2 Suppl):S32–S37. [PubMed] [Google Scholar]
  69. Weström L. Decrease in incidence of women treated in hospital for acute salpingitis in Sweden. Genitourin Med. 1988 Feb;64(1):59–63. [PMC free article] [PubMed] [Google Scholar]
  70. Weström L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):880–892. doi: 10.1016/0002-9378(80)91077-7. [DOI] [PubMed] [Google Scholar]
  71. Wølner-Hanssen P., Eschenbach D. A., Paavonen J., Kiviat N., Stevens C. E., Critchlow C., DeRouen T., Holmes K. K. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA. 1990 Jan 5;263(1):54–59. doi: 10.1001/jama.1990.03440010052029. [DOI] [PubMed] [Google Scholar]
  72. Wølner-Hanssen P., Eschenbach D. A., Paavonen J., Stevens C. E., Kiviat N. B., Critchlow C., DeRouen T., Koutsky L., Holmes K. K. Association between vaginal douching and acute pelvic inflammatory disease. JAMA. 1990 Apr 11;263(14):1936–1941. doi: 10.1001/jama.1990.03440140062032. [DOI] [PubMed] [Google Scholar]
  73. Wølner-Hanssen P., Paavonen J., Kiviat N., Young M., Eschenbach D. A., Holmes K. K. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline. Obstet Gynecol. 1988 Apr;71(4):595–600. [PubMed] [Google Scholar]
  74. Wølner-Hanssen P. Silent pelvic inflammatory disease: is it overstated? Obstet Gynecol. 1995 Sep;86(3):321–325. doi: 10.1016/0029-7844(95)00177-S. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES